Search results
Results from the WOW.Com Content Network
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.The company has three commercially approved medicines: Spinraza (), Tegsedi (), and Waylivra (Volanesorsen), and has four drugs in pivotal studies: tominersen for Huntington's disease (together with Roche), tofersen for SOD1-ALS, AKCEA ...
Ionis' application for the drug was based on data from a late-stage study in which it helped reduce triglyceride levels by 44% in patients, compared to a placebo.
For premium support please call: 800-290-4726 more ways to reach us
The U.S. Food and Drug Administration (FDA) on Thursday approved Ionis Pharmaceuticals and partner AstraZeneca's drug to treat nerve damage caused by a life-shortening rare disease. The drug ...
Ionos SE ([]; proper spelling IONOS) is a German Internet service provider that is known for its web hosting, domain and cloud computing products. The company is part of the United Internet Group and operates in several continental European countries, (excluding Portugal) the UK and North America.
The Southern California News Group (SCNG), formerly the San Gabriel Valley News Group and the Los Angeles News Group, is an umbrella group of local daily newspapers published in the greater Los Angeles area of southern California by Digital First Media, which is owned by the hedge fund Alden Global Capital.
Ionis Pharmaceuticals Stock Price And Volume Action Ionis Pharmaceuticals (NASDAQ:IONS) is currently down 17.47% to a price of $46.29. Tuesday the stock has been traded at a volume of 2.55 million ...
For premium support please call: 800-290-4726 more ways to reach us